Acorah Software Products - Accounts Production 16.4.675 false true 31 October 2023 1 November 2022 false 1 November 2023 31 October 2024 31 October 2024 08725656 Mr C Dott Christopher Dott false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08725656 2023-10-31 08725656 2024-10-31 08725656 2023-11-01 2024-10-31 08725656 frs-core:ComputerEquipment 2023-11-01 2024-10-31 08725656 frs-core:ShareCapital 2024-10-31 08725656 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31 08725656 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 08725656 frs-bus:AbridgedAccounts 2023-11-01 2024-10-31 08725656 frs-bus:SmallEntities 2023-11-01 2024-10-31 08725656 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 08725656 frs-bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 08725656 frs-bus:OrdinaryShareClass1 2023-11-01 2024-10-31 08725656 frs-bus:OrdinaryShareClass1 2024-10-31 08725656 1 2023-11-01 2024-10-31 08725656 frs-bus:Director1 2023-11-01 2024-10-31 08725656 frs-countries:EnglandWales 2023-11-01 2024-10-31 08725656 2022-10-31 08725656 2023-10-31 08725656 2022-11-01 2023-10-31 08725656 frs-core:ShareCapital 2023-10-31 08725656 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31 08725656 frs-bus:OrdinaryShareClass1 2022-11-01 2023-10-31
Registered number: 08725656
CSD Pharma Consulting Ltd
ABRIDGED Financial Statements
For The Year Ended 31 October 2024
Bailey Oster
Chartered Accountants
Mellor House
St Petersgate
Stockport
SK1 1DS
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3—4
Page 1
Abridged Balance Sheet
Registered number: 08725656
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 571 252
571 252
CURRENT ASSETS
Cash at bank and in hand 73,622 17,479
73,622 17,479
Creditors: Amounts Falling Due Within One Year (42,796 ) (2,348 )
NET CURRENT ASSETS (LIABILITIES) 30,826 15,131
TOTAL ASSETS LESS CURRENT LIABILITIES 31,397 15,383
NET ASSETS 31,397 15,383
CAPITAL AND RESERVES
Called up share capital 5 100 100
Profit and Loss Account 31,297 15,283
SHAREHOLDERS' FUNDS 31,397 15,383
Page 1
Page 2
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 October 2024 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mr C Dott
Director
1 August 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
CSD Pharma Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08725656 . The registered office is The Old Cottage, Whitewood Lane, South Godstone, Surrey, RH9 8JR.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and form the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 33% reducing balance
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
Average number of employees, including directors, during the year was:
2024 2023
Office and administration 1 1
1 1
Page 3
Page 4
4. Tangible Assets
Total
£
Cost
As at 1 November 2023 1,653
Additions 600
As at 31 October 2024 2,253
Depreciation
As at 1 November 2023 1,401
Provided during the period 281
As at 31 October 2024 1,682
Net Book Value
As at 31 October 2024 571
As at 1 November 2023 252
5. Share Capital
2024 2023
Allotted, called up and fully paid £ £
100 Ordinary Shares of £ 1 each 100 100
6. Controlling Party
The company's controlling party is Christopher Dott by virtue of his ownership of 60% of the issued share capital in the company.
Page 4